{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T14:18:07Z","timestamp":1788445087550,"version":"build-2803163510"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Innsbruck and Medical University of Innsbruck"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"DOI":"10.1007\/s13346-026-02211-9","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T13:56:22Z","timestamp":1788443782000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["About the impact of medium chain fatty acids on the permeation enhancing effects of self-emulsifying drug delivery systems"],"prefix":"10.1007","author":[{"given":"Annika","family":"Postina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lana","family":"Molnar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4187-8277","authenticated-orcid":false,"given":"Andreas","family":"Bernkop-Schn\u00fcrch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"2211_CR1","doi-asserted-by":"publisher","first-page":"618411","DOI":"10.3389\/fphar.2021.618411","volume":"12","author":"MS Alqahtani","year":"2021","unstructured":"Alqahtani MS, Kazi M, Alsenaidy MA, Ahmad MZ. Advances in oral drug delivery. Front Pharmacol. 2021;12:618411 https:\/\/doi.org\/10.3389\/fphar.2021.618411","journal-title":"Front Pharmacol"},{"key":"2211_CR2","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1080\/10717544.2018.1501119","volume":"25","author":"J Reinholz","year":"2018","unstructured":"Reinholz J, Landfester K, Mail\u00e4nder V. The challenges of oral drug delivery via nanocarriers. Drug Deliv. 2018;25:1694\u2013705. https:\/\/doi.org\/10.1080\/10717544.2018.1501119","journal-title":"Drug Deliv"},{"key":"2211_CR3","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3390\/ph15080975","volume":"15","author":"M Azman","year":"2022","unstructured":"Azman M, Sabri AH, Anjani QK, Mustaffa MF, Hamid KA. Intestinal absorption study: challenges and absorption enhancement strategies in improving oral drug delivery. Pharmaceuticals. 2022;15:975 https:\/\/doi.org\/10.3390\/ph15080975","journal-title":"Pharmaceuticals"},{"key":"2211_CR4","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/nrd1067","volume":"2","author":"M Goldberg","year":"2003","unstructured":"Goldberg M, Gomez-Orellana I. Challenges for the oral delivery of macromolecules. Nat Rev Drug Discov. 2003;2:289\u201395. https:\/\/doi.org\/10.1038\/nrd1067","journal-title":"Nat Rev Drug Discov"},{"key":"2211_CR5","doi-asserted-by":"publisher","first-page":"114097","DOI":"10.1016\/j.addr.2021.114097","volume":"182","author":"S Haddadzadegan","year":"2022","unstructured":"Haddadzadegan S, Dorkoosh F, Bernkop-Schn\u00fcrch A. Oral delivery of therapeutic peptides and proteins: technology landscape of lipid-based nanocarriers. Adv Drug Deliv Rev. 2022;182:114097 https:\/\/doi.org\/10.1016\/j.addr.2021.114097","journal-title":"Adv Drug Deliv Rev"},{"key":"2211_CR6","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.3390\/pharmaceutics12121194","volume":"12","author":"AB Buya","year":"2020","unstructured":"Buya AB, Beloqui A, Memvanga PB, Pr\u00e9at V. Self-nano-emulsifying drug-delivery systems: from the development to the current applications and challenges in oral drug delivery. Pharmaceutics. 2020;12:1194 https:\/\/doi.org\/10.3390\/pharmaceutics12121194","journal-title":"Pharmaceutics"},{"key":"2211_CR7","doi-asserted-by":"publisher","first-page":"102848","DOI":"10.1016\/j.cis.2023.102848","volume":"313","author":"H Spleis","year":"2023","unstructured":"Spleis H, Sandmeier M, Claus V, Bernkop-Schn\u00fcrch A. Surface design of nanocarriers: key to more efficient oral drug delivery systems. Adv Colloid Interface Sci. 2023;313:102848 https:\/\/doi.org\/10.1016\/j.cis.2023.102848","journal-title":"Adv Colloid Interface Sci"},{"key":"2211_CR8","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.addr.2018.07.001","volume":"142","author":"A Mahmood","year":"2019","unstructured":"Mahmood A, Bernkop-Schn\u00fcrch A. SEDDS: a game changing approach for the oral administration of hydrophilic macromolecular drugs. Adv Drug Deliv Rev. 2019;142:91\u2013101. https:\/\/doi.org\/10.1016\/j.addr.2018.07.001","journal-title":"Adv Drug Deliv Rev"},{"key":"2211_CR9","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.ijpharm.2017.03.027","volume":"523","author":"G Het\u00e9nyi","year":"2017","unstructured":"Het\u00e9nyi G, Griesser J, Moser M, Demarne F, Jannin V, Bernkop-Schn\u00fcrch A. Comparison of the protective effect of self-emulsifying peptide drug delivery systems towards intestinal proteases and glutathione. Int J Pharm. 2017;523:357\u201365. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.03.027","journal-title":"Int J Pharm"},{"key":"2211_CR10","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ijpharm.2016.04.044","volume":"508","author":"G Leonaviciute","year":"2016","unstructured":"Leonaviciute G, Zupan\u010di\u010d O, Pr\u00fcfert F, Rohrer J, Bernkop-Schn\u00fcrch A. Impact of lipases on the protective effect of SEDDS for incorporated peptide drugs towards intestinal peptidases. Int J Pharm. 2016;508:102\u20138. https:\/\/doi.org\/10.1016\/j.ijpharm.2016.04.044","journal-title":"Int J Pharm"},{"key":"2211_CR11","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1007\/s13346-025-01852-6","volume":"16","author":"A Postina","year":"2025","unstructured":"Postina A, To D, Z\u00f6ller K, Bernkop-Schn\u00fcrch A. Oral peptide drug delivery: design of SEDDS providing a protective effect against intestinal membrane-bound enzymes. Drug Deliv Transl Res. 2025;16:2115\u201329. https:\/\/doi.org\/10.1007\/s13346-025-01852-6","journal-title":"Drug Deliv Transl Res"},{"key":"2211_CR12","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.ijpharm.2019.02.014","volume":"560","author":"J Liu","year":"2019","unstructured":"Liu J, Werner U, Funke M, Besenius M, Saaby L, Fan\u00f8 M, et al. SEDDS for intestinal absorption of insulin: application of Caco-2 and Caco-2\/HT29 co-culture monolayers and intra-jejunal instillation in rats. Int J Pharm. 2019;560:377\u201384. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.02.014","journal-title":"Int J Pharm"},{"key":"2211_CR13","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.2217\/nnm-2020-0127","volume":"15","author":"JD Friedl","year":"2020","unstructured":"Friedl JD, Steinbring C, Zaichik S, Le N-MN, Bernkop-Schn\u00fcrch A. Cellular uptake of self-emulsifying drug-delivery systems: polyethylene glycol versus polyglycerol surface. Nanomedicine. 2020;15:1829\u201341. https:\/\/doi.org\/10.2217\/nnm-2020-0127","journal-title":"Nanomedicine"},{"key":"2211_CR14","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1007\/s11095-008-9542-2","volume":"25","author":"K Whitehead","year":"2008","unstructured":"Whitehead K, Mitragotri S. Mechanistic analysis of chemical permeation enhancers for oral drug delivery. Pharm Res. 2008;25:1412\u20139. https:\/\/doi.org\/10.1007\/s11095-008-9542-2","journal-title":"Pharm Res"},{"key":"2211_CR15","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1002\/(SICI)1520-6017(200004)89:4<429::AID-JPS1>3.0.CO;2-J","volume":"89","author":"BJ Aungst","year":"2000","unstructured":"Aungst BJ. Intestinal permeation enhancers. J Pharm Sci. 2000;89:429\u201342. 10.1002\/(SICI)1520-6017(200004)89:4<429::AID-JPS1>3.0.CO;2-J","journal-title":"J Pharm Sci"},{"key":"2211_CR16","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3109\/03639040903117348","volume":"36","author":"H Sohi","year":"2010","unstructured":"Sohi H, Ahuja A, Ahmad FJ, Khar RK. Critical evaluation of permeation enhancers for oral mucosal drug delivery. Drug Dev Ind Pharm. 2010;36:254\u201382. https:\/\/doi.org\/10.3109\/03639040903117348","journal-title":"Drug Dev Ind Pharm"},{"key":"2211_CR17","doi-asserted-by":"publisher","first-page":"e113","DOI":"10.1016\/j.ddtec.2011.11.006","volume":"9","author":"S Maher","year":"2012","unstructured":"Maher S, Brayden DJ. Overcoming poor permeability: translating permeation enhancers for oral peptide delivery. Drug Discov Today Technol. 2012;9:e113\u2013e119. https:\/\/doi.org\/10.1016\/j.ddtec.2011.11.006","journal-title":"Drug Discov Today Technol"},{"key":"2211_CR18","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1016\/j.xphs.2018.02.012","volume":"107","author":"J Heade","year":"2018","unstructured":"Heade J, Maher S, Bleiel SB, Brayden DJ. Labrasol\u00ae and salts of medium-chain fatty acids can be combined in low concentrations to increase the permeability of a macromolecule marker across isolated rat intestinal mucosae. J Pharm Sci. 2018;107:1648\u201355. https:\/\/doi.org\/10.1016\/j.xphs.2018.02.012","journal-title":"J Pharm Sci"},{"key":"2211_CR19","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1208\/s12248-014-9634-3","volume":"16","author":"DJ Brayden","year":"2014","unstructured":"Brayden DJ, Walsh E. Efficacious intestinal permeation enhancement induced by the sodium salt of 10-undecylenic acid, a medium chain fatty acid derivative. AAPS J. 2014;16:1064\u201376. https:\/\/doi.org\/10.1208\/s12248-014-9634-3","journal-title":"AAPS J"},{"key":"2211_CR20","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/S0022-3565(25)12150-2","volume":"275","author":"T Lindmark","year":"1995","unstructured":"Lindmark T, Nikkil\u00e4 T, Artursson P. Mechanisms of absorption enhancement by medium chain fatty acids in intestinal epithelial Caco-2 cell monolayers. J Pharmacol Exp Ther. 1995;275:958\u201364. https:\/\/doi.org\/10.1016\/S0022-3565(25)12150-2","journal-title":"J Pharmacol Exp Ther"},{"key":"2211_CR21","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1007\/s11095-014-1303-9","volume":"31","author":"S Tuvia","year":"2014","unstructured":"Tuvia S, Pelled D, Marom K, Salama P, Levin-Arama M, Karmeli I, et al. A novel suspension formulation enhances intestinal absorption of macromolecules via transient and reversible transport mechanisms. Pharm Res. 2014;31:2010\u201321. https:\/\/doi.org\/10.1007\/s11095-014-1303-9","journal-title":"Pharm Res"},{"key":"2211_CR22","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1080\/17425247.2021.1942838","volume":"18","author":"DJ Brayden","year":"2021","unstructured":"Brayden DJ, Maher S. Transient permeation Enhancer\u00ae (TPE\u00ae) technology for oral delivery of octreotide: a technological evaluation. Expert Opin Drug Deliv. 2021;18:1501\u201312. https:\/\/doi.org\/10.1080\/17425247.2021.1942838","journal-title":"Expert Opin Drug Deliv"},{"key":"2211_CR23","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.4155\/tde.11.132","volume":"2","author":"EG Walsh","year":"2011","unstructured":"Walsh EG, Adamczyk BE, Chalasani KB, Maher S, O\u2019Toole EB, Fox JS, et al. Oral delivery of macromolecules: rationale underpinning Gastrointestinal Permeation Enhancement Technology (GIPET \u00ae). Ther Deliv. 2011;2:1595\u2013610. https:\/\/doi.org\/10.4155\/tde.11.132","journal-title":"Ther Deliv"},{"key":"2211_CR24","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1517\/17425247.3.5.685","volume":"3","author":"TW Leonard","year":"2006","unstructured":"Leonard TW, Lynch J, McKenna MJ, Brayden DJ. Promoting absorption of drugs in humans using medium-chain fatty acid-based solid dosage forms: GIPETTM. Expert Opin Drug Deliv. 2006;3:685\u201392. https:\/\/doi.org\/10.1517\/17425247.3.5.685","journal-title":"Expert Opin Drug Deliv"},{"key":"2211_CR25","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.3390\/ph15121585","volume":"15","author":"JC Kim","year":"2022","unstructured":"Kim JC, Park EJ, Na DH. Gastrointestinal permeation enhancers for the development of oral peptide pharmaceuticals. Pharmaceuticals. 2022;15:1585 https:\/\/doi.org\/10.3390\/ph15121585","journal-title":"Pharmaceuticals"},{"key":"2211_CR26","doi-asserted-by":"publisher","first-page":"105336","DOI":"10.1016\/j.chemphyslip.2023.105336","volume":"256","author":"S Mitra","year":"2023","unstructured":"Mitra S, Sharma VK, Ghosh SK. Effects of ionic liquids on biomembranes: a review on recent biophysical studies. Chem Phys Lipids. 2023;256:105336 https:\/\/doi.org\/10.1016\/j.chemphyslip.2023.105336","journal-title":"Chem Phys Lipids"},{"key":"2211_CR27","doi-asserted-by":"publisher","first-page":"111795","DOI":"10.1016\/j.colsurfb.2021.111795","volume":"204","author":"GM Demirbolat","year":"2021","unstructured":"Demirbolat GM, Coskun GP, Erdogan O, Cevik O. Long chain fatty acids can form aggregates and affect the membrane integrity. Colloids Surf B Biointerfaces. 2021;204:111795 https:\/\/doi.org\/10.1016\/j.colsurfb.2021.111795","journal-title":"Colloids Surf B Biointerfaces"},{"key":"2211_CR28","unstructured":"US9089484B2 - Pharmaceutical compositions of selective factor Xa inhibitors for oral administration - Google Patents. https:\/\/patents.google.com\/patent\/US9089484B2\/en. Accessed 19 Mar 2026"},{"key":"2211_CR29","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/J.EJPB.2017.03.012","volume":"115","author":"Saskia K\u00f6llner","year":"2017","unstructured":"K\u00f6llner S, Nardin I, Markt R, Griesser J, Pr\u00fcfert F, Bernkop-Schn\u00fcrch A. Self-emulsifying drug delivery systems: design of a novel vaginal delivery system for curcumin. Eur J Pharmaceutics Biopharmaceutics. 2017;115:268\u201375. https:\/\/doi.org\/10.1016\/J.EJPB.2017.03.012","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"key":"2211_CR30","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1021\/acs.molpharmaceut.1c00724","volume":"19","author":"S Berg","year":"2022","unstructured":"Berg S, K\u00e4rrberg L, Suljovic D, Seeliger F, S\u00f6derberg M, Perez-Alcazar M, et al. Impact of intestinal concentration and colloidal structure on the permeation-enhancing efficiency of sodium caprate in the rat. Mol Pharm. 2022;19:200\u201312. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.1c00724","journal-title":"Mol Pharm"},{"key":"2211_CR31","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.ejpb.2014.12.024","volume":"97","author":"I Pereira de Sousa","year":"2015","unstructured":"Pereira de Sousa I, Steiner C, Schmutzler M, Wilcox MD, Veldhuis GJ, Pearson JP, et al. Mucus permeating carriers: formulation and characterization of highly densely charged nanoparticles. Eur J Pharmaceutics Biopharmaceutics. 2015;97:273\u20139. https:\/\/doi.org\/10.1016\/j.ejpb.2014.12.024","journal-title":"Eur J Pharmaceutics Biopharmaceutics"},{"key":"2211_CR32","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1007\/s13346-025-01990-x","volume":"16","author":"A Spennacchio","year":"2025","unstructured":"Spennacchio A, Richter LM, Stengel D, Hermann M, Lopedota AA, Lopalco A, et al. Exploring the impact of various zwitterionic surface modifications on the mucus diffusion and membrane permeability of lipid-based nanocarriers. Drug Deliv Transl Res. 2025;16:1894\u2013911. https:\/\/doi.org\/10.1007\/s13346-025-01990-x","journal-title":"Drug Deliv Transl Res"},{"key":"2211_CR33","doi-asserted-by":"publisher","first-page":"4406","DOI":"10.1002\/jps.23757","volume":"102","author":"H Friedl","year":"2013","unstructured":"Friedl H, D\u00fcnnhaupt S, Hintzen F, Waldner C, Parikh S, Pearson JP, et al. Development and evaluation of a novel mucus diffusion test system approved by self-nanoemulsifying drug delivery systems. J Pharm Sci. 2013;102:4406\u201313. https:\/\/doi.org\/10.1002\/jps.23757","journal-title":"J Pharm Sci"},{"key":"2211_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-022-01539-x","volume":"20","author":"DA Subramanian","year":"2022","unstructured":"Subramanian DA, Langer R, Traverso G. Mucus interaction to improve gastrointestinal retention and pharmacokinetics of orally administered nano-drug delivery systems. J Nanobiotechnology. 2022;20:362 https:\/\/doi.org\/10.1186\/s12951-022-01539-x","journal-title":"J Nanobiotechnology"},{"key":"2211_CR35","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jconrel.2022.09.034","volume":"352","author":"JS Mortensen","year":"2022","unstructured":"Mortensen JS, Bohr SS-R, Harloff-Helleberg S, Hatzakis NS, Saaby L, Nielsen HM. Physical and barrier changes in gastrointestinal mucus induced by the permeation enhancer sodium 8-[(2-hydroxybenzoyl)amino]octanoate (SNAC). J Controlled Rel. 2022;352:163\u201378. https:\/\/doi.org\/10.1016\/j.jconrel.2022.09.034","journal-title":"J Controlled Rel"},{"key":"2211_CR36","doi-asserted-by":"publisher","unstructured":"Evans BC, Nelson CE, Yu SS, Beavers KR, Kim AJ, Li H, et al. Ex vivo red blood cell hemolysis assay for the evaluation of pH-responsive endosomolytic agents for cytosolic delivery of biomacromolecular drugs. J Visualized Exp. 2013:50166. https:\/\/doi.org\/10.3791\/50166.","DOI":"10.3791\/50166"},{"key":"2211_CR37","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.tifs.2020.11.015","volume":"107","author":"X Ding","year":"2021","unstructured":"Ding X, Hu X, Chen Y, Xie J, Ying M, Wang Y, et al. Differentiated Caco-2 cell models in food-intestine interaction study: current applications and future trends. Trends Food Sci Technol. 2021;107:455\u201365. https:\/\/doi.org\/10.1016\/j.tifs.2020.11.015","journal-title":"Trends Food Sci Technol"},{"key":"2211_CR38","doi-asserted-by":"crossref","unstructured":"Lea T Caco-2 cell line. In: The Impact of Food Bioactives on Health. Cham: Springer International Publishing; 2015. pp. 103-11.","DOI":"10.1007\/978-3-319-16104-4_10"},{"key":"2211_CR39","doi-asserted-by":"publisher","first-page":"106628","DOI":"10.1016\/j.jddst.2025.106628","volume":"105","author":"K Z\u00f6ller","year":"2025","unstructured":"Z\u00f6ller K, Lindner S, To D, Postina A, Bernkop-Schn\u00fcrch A. Enhanced cytotoxicity of exo- and endogenous compounds by hitchhiking lipid-based nanocarriers. J Drug Deliv Sci Technol. 2025;105:106628 https:\/\/doi.org\/10.1016\/j.jddst.2025.106628","journal-title":"J Drug Deliv Sci Technol"},{"key":"2211_CR40","doi-asserted-by":"publisher","first-page":"122753","DOI":"10.1016\/j.ijpharm.2023.122753","volume":"635","author":"P Knoll","year":"2023","unstructured":"Knoll P, Francesco Racaniello G, Laquintana V, Veider F, Saleh A, Seybold A, et al. Lipid-based nanoparticles: enhanced cellular uptake via surface thiolation. Int J Pharm. 2023;635:122753 https:\/\/doi.org\/10.1016\/j.ijpharm.2023.122753","journal-title":"Int J Pharm"},{"key":"2211_CR41","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1177\/0300985814559404","volume":"52","author":"JM Williams","year":"2015","unstructured":"Williams JM, Duckworth CA, Burkitt MD, Watson AJM, Campbell BJ, Pritchard DM. Epithelial cell shedding and barrier function: a matter of life and death at the small intestinal villus tip. Vet Pathol. 2015;52:445 https:\/\/doi.org\/10.1177\/0300985814559404","journal-title":"Vet Pathol"},{"key":"2211_CR42","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/J.JCONREL.2022.04.016","volume":"346","author":"G Kali","year":"2022","unstructured":"Kali G, Knoll P, Bernkop-Schn\u00fcrch A. Emerging technologies to increase gastrointestinal transit times of drug delivery systems. J Controlled Rel. 2022;346:289\u201399. https:\/\/doi.org\/10.1016\/J.JCONREL.2022.04.016","journal-title":"J Controlled Rel"},{"key":"2211_CR43","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/J.JCIS.2022.07.160","volume":"628","author":"P Knoll","year":"2022","unstructured":"Knoll P, H\u00f6rmann N, Nguyen Le NM, Wibel R, Gust R, Bernkop-Schn\u00fcrch A. Charge converting nanostructured lipid carriers containing a cell-penetrating peptide for enhanced cellular uptake. J Colloid Interface Sci. 2022;628:463\u201375. https:\/\/doi.org\/10.1016\/J.JCIS.2022.07.160","journal-title":"J Colloid Interface Sci"},{"key":"2211_CR44","doi-asserted-by":"publisher","first-page":"100981","DOI":"10.1016\/j.carpta.2025.100981","volume":"11","author":"D Gintsburg","year":"2025","unstructured":"Gintsburg D, Kreuzer P, Afzal KB, Polidori I, Truszkowska M, Seybold A, et al. Cyclodextrin-based polyrotaxanes: cellular uptake enhancement effect of different functionality types. Carbohydr Polym Technol Appl. 2025;11:100981 https:\/\/doi.org\/10.1016\/j.carpta.2025.100981","journal-title":"Carbohydr Polym Technol Appl"},{"key":"2211_CR45","doi-asserted-by":"publisher","first-page":"2302034","DOI":"10.1002\/adhm.202302034","volume":"12","author":"AM J\u00f6rgensen","year":"2023","unstructured":"J\u00f6rgensen AM, Steinbring C, Stengel D, To D, Schmid P, Bernkop\u2010Schn\u00fcrch A. Self\u2010Emulsifying Drug Delivery Systems (SEDDS) containing reverse micelles: advanced oral formulations for therapeutic peptides. Adv Healthc Mater. 2023;12:2302034 https:\/\/doi.org\/10.1002\/adhm.202302034","journal-title":"Adv Healthc Mater"},{"key":"2211_CR46","doi-asserted-by":"publisher","first-page":"4880","DOI":"10.1021\/acs.biomac.3c00577","volume":"24","author":"G Kali","year":"2023","unstructured":"Kali G, \u00d6zkahraman B, Laffleur F, Knoll P, Wibel R, Z\u00f6ller K, et al. Thiolated cellulose: a dual-acting mucoadhesive and permeation-enhancing polymer. Biomacromolecules. 2023;24:4880\u20139. https:\/\/doi.org\/10.1021\/acs.biomac.3c00577","journal-title":"Biomacromolecules"},{"key":"2211_CR47","doi-asserted-by":"publisher","first-page":"113795","DOI":"10.1016\/j.addr.2021.05.005","volume":"175","author":"Y Xu","year":"2021","unstructured":"Xu Y, Shrestha N, Pr\u00e9at V, Beloqui A. An overview of in vitro, ex vivo and in vivo models for studying the transport of drugs across intestinal barriers. Adv Drug Deliv Rev. 2021;175:113795 https:\/\/doi.org\/10.1016\/j.addr.2021.05.005","journal-title":"Adv Drug Deliv Rev"},{"key":"2211_CR48","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/pharmaceutics10020057","volume":"10","author":"M Danaei","year":"2018","unstructured":"Danaei M, Dehghankhold M, Ataei S, Hasanzadeh Davarani F, Javanmard R, Dokhani A, et al. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics. 2018;10:57 https:\/\/doi.org\/10.3390\/pharmaceutics10020057","journal-title":"Pharmaceutics"},{"key":"2211_CR49","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1007\/s00396-023-05154-6","volume":"301","author":"M Pis\u00e1r\u010dik","year":"2023","unstructured":"Pis\u00e1r\u010dik M, Bajcura M, Luk\u00e1\u010d M, Dev\u00ednsky F, Bilkov\u00e1 A, Bilka F, et al. Self-aggregation of cationic gemini surfactants with amide groups in the spacer and variable alkyl chain length. Colloid Polym Sci. 2023;301:1379\u201392. https:\/\/doi.org\/10.1007\/s00396-023-05154-6","journal-title":"Colloid Polym Sci"},{"key":"2211_CR50","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1208\/s12249-007-9014-8","volume":"9","author":"V Borhade","year":"2008","unstructured":"Borhade V, Nair H, Hegde D. Design and evaluation of self-microemulsifying drug delivery system (SMEDDS) of tacrolimus. AAPS Pharm Sci Tech. 2008;9:13\u201321. https:\/\/doi.org\/10.1208\/s12249-007-9014-8","journal-title":"AAPS Pharm Sci Tech"},{"key":"2211_CR51","doi-asserted-by":"publisher","first-page":"20.6.1","DOI":"10.1002\/0471140856.tx2006s47","volume":"47","author":"I De Angelis","year":"2011","unstructured":"De Angelis I, Turco L. Caco\u20102 cells as a model for intestinal absorption. Curr Protoc Toxicol. 2011;47:20.6.1\u201320.6.15. https:\/\/doi.org\/10.1002\/0471140856.tx2006s47","journal-title":"Curr Protoc Toxicol"},{"key":"2211_CR52","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/nmat2202","volume":"7","author":"A Verma","year":"2008","unstructured":"Verma A, Uzun O, Hu Y, Hu Y, Han H-S, Watson N, et al. Surface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticles. Nat Mater. 2008;7:588\u201395. https:\/\/doi.org\/10.1038\/nmat2202","journal-title":"Nat Mater"},{"key":"2211_CR53","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.xphs.2019.11.009","volume":"109","author":"K Bunchongprasert","year":"2020","unstructured":"Bunchongprasert K, Shao J. Impact of media in transport study on cell monolayer integrity and permeability. J Pharm Sci. 2020;109:1145\u201352. https:\/\/doi.org\/10.1016\/j.xphs.2019.11.009","journal-title":"J Pharm Sci"},{"key":"2211_CR54","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.ijpharm.2004.09.018","volume":"288","author":"J Weyermann","year":"2005","unstructured":"Weyermann J, Lochmann D, Zimmer A. A practical note on the use of cytotoxicity assays. Int J Pharm. 2005;288:369\u201376. https:\/\/doi.org\/10.1016\/j.ijpharm.2004.09.018","journal-title":"Int J Pharm"},{"key":"2211_CR55","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1021\/bc800194e","volume":"19","author":"J Mueller","year":"2008","unstructured":"Mueller J, Kretzschmar I, Volkmer R, Boisguerin P. Comparison of cellular uptake using 22 CPPs in 4 different cell lines. Bioconjug Chem. 2008;19:2363\u201374. https:\/\/doi.org\/10.1021\/bc800194e","journal-title":"Bioconjug Chem"},{"key":"2211_CR56","doi-asserted-by":"crossref","unstructured":"Khadke S, MacDougall F, Islam T Novel formulation approaches for gastrointestinal targeting: characterization and animal model considerations. In: Oral Delivery of Therapeutic Peptides and Proteins. Elsevier; 2022, pp. 167-98.","DOI":"10.1016\/B978-0-12-821061-1.00005-8"},{"key":"2211_CR57","doi-asserted-by":"publisher","first-page":"390","DOI":"10.5056\/jnm19195","volume":"27","author":"MW Klinge","year":"2021","unstructured":"Klinge MW, Sutter N, Mark EB, Haase A-M, Borghammer P, Schlageter V, et al. Gastric emptying time and volume of the small intestine as objective markers in patients with symptoms of diabetic enteropathy. J Neurogastroenterol Motil. 2021;27:390\u20139. https:\/\/doi.org\/10.5056\/jnm19195","journal-title":"J Neurogastroenterol Motil"},{"key":"2211_CR58","doi-asserted-by":"publisher","first-page":"773372","DOI":"10.3389\/FVETS.2021.773372","volume":"8","author":"LM Gomez-Osorio","year":"2021","unstructured":"Gomez-Osorio LM, Yepes-Medina V, Ballou A, Parini M, Angel R. Short and medium chain fatty acids and their derivatives as a natural strategy in the control of necrotic enteritis and microbial homeostasis in broiler chickens. Front Vet Sci. 2021;8:773372 https:\/\/doi.org\/10.3389\/FVETS.2021.773372","journal-title":"Front Vet Sci"},{"key":"2211_CR59","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1021\/nn3059295","volume":"7","author":"D H\u00fchn","year":"2013","unstructured":"H\u00fchn D, Kantner K, Geidel C, Brandholt S, De Cock I, Soenen SJH, et al. Polymer-coated nanoparticles interacting with proteins and cells: focusing on the sign of the net charge. ACS Nano. 2013;7:3253\u201363. https:\/\/doi.org\/10.1021\/nn3059295","journal-title":"ACS Nano"},{"key":"2211_CR60","doi-asserted-by":"publisher","first-page":"3200","DOI":"10.1007\/s13346-024-01541-w","volume":"14","author":"B Le-Vinh","year":"2024","unstructured":"Le-Vinh B, Le N-MN, Phan TNQ, Lam HT, Bernkop-Schn\u00fcrch A. Effects of excipients on the interactions of self-emulsifying drug delivery systems with human blood plasma and plasma membranes. Drug Deliv Transl Res. 2024;14:3200\u201311. https:\/\/doi.org\/10.1007\/s13346-024-01541-w","journal-title":"Drug Deliv Transl Res"},{"key":"2211_CR61","doi-asserted-by":"publisher","first-page":"1456939","DOI":"10.3389\/fnano.2024.1456939","volume":"6","author":"P-D Ly","year":"2024","unstructured":"Ly P-D, Ly K-N, Phan H-L, Nguyen HHT, Duong V-A, Nguyen HV. Recent advances in surface decoration of nanoparticles in drug delivery. Front Nanotechnol. 2024;6:1456939 https:\/\/doi.org\/10.3389\/fnano.2024.1456939","journal-title":"Front Nanotechnol"},{"key":"2211_CR62","doi-asserted-by":"publisher","first-page":"6975","DOI":"10.1021\/acs.langmuir.3c00133","volume":"39","author":"B Ding","year":"2023","unstructured":"Ding B, Ahmadi SH, Babak P, Bryant SL, Kantzas A. On the stability of pickering and classical nanoemulsions: theory and experiments. Langmuir. 2023;39:6975\u201391. https:\/\/doi.org\/10.1021\/acs.langmuir.3c00133","journal-title":"Langmuir"},{"key":"2211_CR63","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1021\/bm501832y","volume":"16","author":"B Menchicchi","year":"2015","unstructured":"Menchicchi B, Fuenzalida JP, Hensel A, Swamy MJ, David L, Rochas C, et al. Biophysical analysis of the molecular interactions between polysaccharides and Mucin. Biomacromolecules. 2015;16:924\u201335. https:\/\/doi.org\/10.1021\/bm501832y","journal-title":"Biomacromolecules"},{"key":"2211_CR64","doi-asserted-by":"publisher","first-page":"105685","DOI":"10.1016\/j.ejps.2020.105685","volume":"158","author":"C Twarog","year":"2021","unstructured":"Twarog C, McCartney F, Harrison SM, Illel B, Fattal E, Brayden DJ. Comparison of the effects of the intestinal permeation enhancers, SNAC and sodium caprate (C10): isolated rat intestinal mucosae and sacs. Eur J Pharm Sci. 2021;158:105685 https:\/\/doi.org\/10.1016\/j.ejps.2020.105685","journal-title":"Eur J Pharm Sci"},{"key":"2211_CR65","doi-asserted-by":"publisher","first-page":"20130027","DOI":"10.1098\/rsif.2013.0027","volume":"10","author":"C de Loubens","year":"2013","unstructured":"de Loubens C, Lentle RG, Love RJ, Hulls C, Janssen PWM. Fluid mechanical consequences of pendular activity, segmentation and pyloric outflow in the proximal duodenum of the rat and the guinea pig. J R Soc Interface. 2013;10:20130027 https:\/\/doi.org\/10.1098\/rsif.2013.0027","journal-title":"J R Soc Interface"},{"key":"2211_CR66","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.actbio.2020.10.031","volume":"119","author":"SP Bandi","year":"2021","unstructured":"Bandi SP, Bhatnagar S, Venuganti VVK. Advanced materials for drug delivery across mucosal barriers. Acta Biomater. 2021;119:13\u201329. https:\/\/doi.org\/10.1016\/j.actbio.2020.10.031","journal-title":"Acta Biomater"},{"key":"2211_CR67","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/bcpt.12342","volume":"116","author":"M Boegh","year":"2015","unstructured":"Boegh M, Nielsen HM. Mucus as a barrier to drug delivery \u2013 understanding and mimicking the barrier properties. Basic Clin Pharmacol Toxicol. 2015;116:179\u201386. https:\/\/doi.org\/10.1111\/bcpt.12342","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"2211_CR68","doi-asserted-by":"publisher","first-page":"107320","DOI":"10.1016\/j.jddst.2025.107320","volume":"113","author":"C Kim","year":"2025","unstructured":"Kim C, Han S, Joo Y, Kim H, Youn YS, Kim J-K, et al. Development of permeation enhancer-Co-loaded solid lipid nanoparticles for enhanced oral bioavailability of alendronate. J Drug Deliv Sci Technol. 2025;113:107320 https:\/\/doi.org\/10.1016\/j.jddst.2025.107320","journal-title":"J Drug Deliv Sci Technol"},{"key":"2211_CR69","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.colsurfb.2015.07.038","volume":"135","author":"BH Bajka","year":"2015","unstructured":"Bajka BH, Rigby NM, Cross KL, Macierzanka A, Mackie AR. The influence of small intestinal mucus structure on particle transport ex vivo. Colloids Surf B Biointerfaces. 2015;135:73\u201380. https:\/\/doi.org\/10.1016\/j.colsurfb.2015.07.038","journal-title":"Colloids Surf B Biointerfaces"},{"key":"2211_CR70","doi-asserted-by":"publisher","first-page":"G922","DOI":"10.1152\/ajpgi.2001.280.5.G922","volume":"280","author":"C Atuma","year":"2001","unstructured":"Atuma C, Strugala V, Allen A, Holm L. The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo. Am J Physiol-Gastrointestinal Liver Physiol. 2001;280:G922\u2013G929. https:\/\/doi.org\/10.1152\/ajpgi.2001.280.5.G922","journal-title":"Am J Physiol-Gastrointestinal Liver Physiol"},{"key":"2211_CR71","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/J.EJPB.2015.01.005","volume":"96","author":"J Grie\u00dfinger","year":"2015","unstructured":"Grie\u00dfinger J, D\u00fcnnhaupt S, Cattoz B, Griffiths P, Oh S, G\u00f3mez SBI, et al. Methods to determine the interactions of micro- and nanoparticles with mucus. Eur J Pharmaceutics Biopharmaceutics. 2015;96:464\u201376. https:\/\/doi.org\/10.1016\/J.EJPB.2015.01.005","journal-title":"Eur J Pharmaceutics Biopharmaceutics"},{"key":"2211_CR72","doi-asserted-by":"crossref","unstructured":"Segeritz C-P, Vallier L Cell culture. In: Basic Science Methods for Clinical Researchers. Elsevier; 2017. pp. 151-72.","DOI":"10.1016\/B978-0-12-803077-6.00009-6"},{"key":"2211_CR73","doi-asserted-by":"publisher","DOI":"10.1021\/acschembio.9b00616","volume":"14","author":"LR Parisi","year":"2019","unstructured":"Parisi LR, Sowlati-Hashjin S, Berhane IA, Galster SL, Carter KA, Lovell JF, et al. Membrane disruption by very long chain fatty acids during necroptosis. ACS Chem Biol. 2019;14:acschembio.9b00616 https:\/\/doi.org\/10.1021\/acschembio.9b00616","journal-title":"ACS Chem Biol"},{"key":"2211_CR74","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.3390\/toxins4111008","volume":"4","author":"P Vesterkvist","year":"2012","unstructured":"Vesterkvist P, Misiorek J, Spoof L, Toivola D, Meriluoto J. Comparative cellular toxicity of hydrophilic and hydrophobic microcystins on Caco-2 cells. Toxins. 2012;4:1008\u201323. https:\/\/doi.org\/10.3390\/toxins4111008","journal-title":"Toxins"},{"key":"2211_CR75","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.ejpb.2014.10.008","volume":"88","author":"DJ Brayden","year":"2014","unstructured":"Brayden DJ, Gleeson J, Walsh EG. A head-to-head multi-parametric high content analysis of a series of medium chain fatty acid intestinal permeation enhancers in Caco-2 cells. Eur J Pharmaceutics Biopharmaceutics. 2014;88:830\u20139. https:\/\/doi.org\/10.1016\/j.ejpb.2014.10.008","journal-title":"Eur J Pharmaceutics Biopharmaceutics"},{"key":"2211_CR76","doi-asserted-by":"publisher","first-page":"114966","DOI":"10.1016\/J.ADDR.2023.114966","volume":"200","author":"CM Wang","year":"2023","unstructured":"Wang CM, Fernez MT, Woolston BM, Carrier RL. Native gastrointestinal mucus: critical features and techniques for studying interactions with drugs, drug carriers, and bacteria. Adv Drug Deliv Rev. 2023;200:114966 https:\/\/doi.org\/10.1016\/J.ADDR.2023.114966","journal-title":"Adv Drug Deliv Rev"},{"key":"2211_CR77","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.bbamem.2016.09.024","volume":"1859","author":"DE Otzen","year":"2017","unstructured":"Otzen DE. Biosurfactants and surfactants interacting with membranes and proteins: same but different? Biochimica et Biophysica Acta - Biomembranes. 2017;1859:639\u201349. https:\/\/doi.org\/10.1016\/j.bbamem.2016.09.024","journal-title":"Biochimica et Biophysica Acta - Biomembranes"},{"key":"2211_CR78","doi-asserted-by":"publisher","first-page":"107648","DOI":"10.1016\/j.ijantimicag.2025.107648","volume":"66","author":"Y Seo","year":"2025","unstructured":"Seo Y, Kim M, Kim D-Y, Park J-W, Kim HJ, Heo K, et al. Membrane-disrupting medium-chain fatty acids reduce Staphylococcus aureus persister cell survival during antibiotic treatment. Int J Antimicrob Agents. 2025;66:107648 https:\/\/doi.org\/10.1016\/j.ijantimicag.2025.107648","journal-title":"Int J Antimicrob Agents"},{"key":"2211_CR79","doi-asserted-by":"publisher","unstructured":"Inai, T. The coculture method to examine interactions between claudin isoforms in tight junction-free HEK293 cells and tight junction-bearing MDCK II cells. Methods in Molecular Biology. Humana Press..2011; 101-114. https:\/\/doi.org\/10.1007\/978-1-61779-185-7_8","DOI":"10.1007\/978-1-61779-185-7_8"},{"key":"2211_CR80","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.1007\/s00018-011-0680-z","volume":"68","author":"J Piontek","year":"2011","unstructured":"Piontek J, Fritzsche S, Cording J, Richter S, Hartwig J, Walter M, et al. Elucidating the principles of the molecular organization of heteropolymeric tight junction strands. Cell Mol Life Sci. 2011;68:3903\u201318. https:\/\/doi.org\/10.1007\/s00018-011-0680-z","journal-title":"Cell Mol Life Sci"},{"key":"2211_CR81","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jconrel.2017.04.013","volume":"256","author":"R Wallbrecher","year":"2017","unstructured":"Wallbrecher R, Ackels T, Olea RA, Klein MJ, Caillon L, Schiller J, et al. Membrane permeation of arginine-rich cell-penetrating peptides independent of transmembrane potential as a function of lipid composition and membrane fluidity. J Controlled Rel. 2017;256:68\u201378. https:\/\/doi.org\/10.1016\/j.jconrel.2017.04.013","journal-title":"J Controlled Rel"},{"key":"2211_CR82","doi-asserted-by":"publisher","first-page":"4861","DOI":"10.3390\/ijms25094861","volume":"25","author":"L Voges","year":"2024","unstructured":"Voges L, Wei\u00df F, Branco A-T, Fromm M, Krug SM. Expression and localization profiles of tight junction proteins in immune cells depend on their activation status. Int J Mol Sci. 2024;25:4861 https:\/\/doi.org\/10.3390\/ijms25094861","journal-title":"Int J Mol Sci"},{"key":"2211_CR83","doi-asserted-by":"publisher","first-page":"30005","DOI":"10.1074\/jbc.M703547200","volume":"282","author":"BL Daugherty","year":"2007","unstructured":"Daugherty BL, Ward C, Smith T, Ritzenthaler JD, Koval M. Regulation of heterotypic claudin compatibility. J Biol Chem. 2007;282:30005\u201313. https:\/\/doi.org\/10.1074\/jbc.M703547200","journal-title":"J Biol Chem"},{"key":"2211_CR84","doi-asserted-by":"publisher","first-page":"2710","DOI":"10.1091\/mbc.e14-02-0773","volume":"25","author":"CT Capaldo","year":"2014","unstructured":"Capaldo CT, Farkas AE, Hilgarth RS, Krug SM, Wolf MF, Benedik JK, et al. Proinflammatory cytokine-induced tight junction remodeling through dynamic self-assembly of claudins. Mol Biol Cell. 2014;25:2710\u20139. https:\/\/doi.org\/10.1091\/mbc.e14-02-0773","journal-title":"Mol Biol Cell"},{"key":"2211_CR85","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.3390\/pharmaceutics15112523","volume":"15","author":"M Kus","year":"2023","unstructured":"Kus M, Ibragimow I, Piotrowska-Kempisty H. Caco-2 cell line standardization with pharmaceutical requirements and in vitro model suitability for permeability assays. Pharmaceutics. 2023;15:2523 https:\/\/doi.org\/10.3390\/pharmaceutics15112523","journal-title":"Pharmaceutics"},{"key":"2211_CR86","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1093\/toxsci\/kfaf011","volume":"204","author":"HL Moyer","year":"2025","unstructured":"Moyer HL, Vergara L, Stephan C, Sakolish C, Ford LC, Tsai H-HD, et al. Comparative analysis of Caco-2 cells and human jejunal and duodenal enteroid-derived cells in gel- and membrane-based barrier models of intestinal permeability. Toxicological Sci. 2025;204:181\u201397. https:\/\/doi.org\/10.1093\/toxsci\/kfaf011","journal-title":"Toxicological Sci"},{"key":"2211_CR87","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1038\/nprot.2007.303","volume":"2","author":"I Hubatsch","year":"2007","unstructured":"Hubatsch I, Ragnarsson EGE, Artursson P. Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers. Nat Protoc. 2007;2:2111\u20139. https:\/\/doi.org\/10.1038\/nprot.2007.303","journal-title":"Nat Protoc"},{"key":"2211_CR88","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1002\/jps.21010","volume":"97","author":"DA Volpe","year":"2008","unstructured":"Volpe DA. Variability in Caco-2 and MDCK cell-based intestinal permeability assays. J Pharm Sci. 2008;97:712\u201325. https:\/\/doi.org\/10.1002\/jps.21010","journal-title":"J Pharm Sci"},{"key":"2211_CR89","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1023\/A:1012102522787","volume":"14","author":"S Yee","year":"1997","unstructured":"Yee S. In vitro permeability across Caco-2 cells (Colonic) can predict in vivo (Small Intestinal) absorption in man\u2014fact or myth. Pharm Res. 1997;14:763\u20136. https:\/\/doi.org\/10.1023\/A:1012102522787","journal-title":"Pharm Res"},{"key":"2211_CR90","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1080\/1061186X.2016.1258703","volume":"25","author":"M Ghadiri","year":"2017","unstructured":"Ghadiri M, Young PM, Jarolimek W, Grau GER, Oliver BGG, Traini D. The effect of non-specific tight junction modulators on the transepithelial transport of poorly permeable drugs across airway epithelial cells. J Drug Target. 2017;25:342\u20139. https:\/\/doi.org\/10.1080\/1061186X.2016.1258703","journal-title":"J Drug Target"},{"key":"2211_CR91","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/S0022-3565(24)37216-7","volume":"284","author":"T Lindmark","year":"1998","unstructured":"Lindmark T, Kimura Y, Artursson P. Absorption enhancement through intracellular regulation of tight junction permeability by medium chain fatty acids in Caco-2 cells. J Pharmacol Exp Ther. 1998;284:362\u20139. https:\/\/doi.org\/10.1016\/S0022-3565(24)37216-7","journal-title":"J Pharmacol Exp Ther"},{"key":"2211_CR92","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.chemphyslip.2016.10.001","volume":"200","author":"A Arouri","year":"2016","unstructured":"Arouri A, Lauritsen KE, Nielsen HL, Mouritsen OG. Effect of fatty acids on the permeability barrier of model and biological membranes. Chem Phys Lipids. 2016;200:139\u201346. https:\/\/doi.org\/10.1016\/j.chemphyslip.2016.10.001","journal-title":"Chem Phys Lipids"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-026-02211-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-026-02211-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-026-02211-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T13:56:24Z","timestamp":1788443784000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-026-02211-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":92,"alternative-id":["2211"],"URL":"https:\/\/doi.org\/10.1007\/s13346-026-02211-9","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]},"assertion":[{"value":"20 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}